National Labs Face Cuts In Accelerator Programs

WASHINGTON--A panel of high-energy physicists has recommended slashing experimental programs at the Stanford Linear Accelerator Center, Fermilab, and Brookhaven National Laboratory in response to expected budget cuts of up to 15 percent to be proposed by the Department of Energy (DOE). The cuts, if contained in the fiscal year 1993 budget that President Bush will submit in January to Congress, could mean layoffs of hundreds of scientists, the early termination of several research efforts, and

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The cuts, if contained in the fiscal year 1993 budget that President Bush will submit in January to Congress, could mean layoffs of hundreds of scientists, the early termination of several research efforts, and the delay or cancellation of several facilities being planned.

The comments of one member of the High Energy Physics Advisory Panel (HEPAP), meeting last month to suggest ways in which DOE could trim its $628 million annual budget for the field, reflected the feelings of the physicists about their uncomfortable task.

"Whatever we do," declared Jonathan Dorfan, a researcher at the Stanford Linear Accelerator Center (SLAC) at one point during the two-day meeting, "our preamble should contain an enormous primal scream of pain."

Sitting in the audience, Melvin Schwartz, a 1988 Nobel laureate in physics who returned to Brookhaven lab this year to direct its high-energy and nuclear energy programs, didn't mince words in describing HEPAP's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies